DAVITA INC. Sale and Leaseback Transaction, Gain (Loss), Net
DAVITA INC. (DVA) reported Sale and Leaseback Transaction, Gain (Loss), Net of $2.26 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:SaleAndLeasebackTransactionGainLossNet · last filed 2025-02-13
- DAVITA INC. sale and leaseback transaction, gain (loss), net for the quarter ending 2020-03-31 was $9.49M, a 138.00% increase year-over-year.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for the quarter ending 2019-12-31 was $6.93M.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for the quarter ending 2019-09-30 was $3.57M.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for the quarter ending 2019-06-30 was $6.35M.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for fiscal 2024 was $2.26M, a 33.27% decline from fiscal 2023.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for fiscal 2023 was $3.39M, a 87.91% decline from fiscal 2022.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for fiscal 2022 was $28.00M, a 63.42% increase from fiscal 2021.
- DAVITA INC. sale and leaseback transaction, gain (loss), net for fiscal 2021 was $17.14M, a 50.04% decline from fiscal 2020.
| Period end | Sale and Leaseback Transaction, Gain (Loss), Net 3 month | Sale and Leaseback Transaction, Gain (Loss), Net 6 month | Sale and Leaseback Transaction, Gain (Loss), Net 9 month | Sale and Leaseback Transaction, Gain (Loss), Net 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.26M 10-K · filed 2025-02-13 | |||
| 2023-12-31 | $3.39M 10-K · filed 2025-02-13 | |||
| 2022-12-31 | $28.00M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $17.14M 10-K · filed 2024-02-14 | |||
| 2020-12-31 | $34.30M 10-K · filed 2023-02-22 | |||
| 2020-03-31 | $9.49M 10-Q · filed 2020-05-05 | $16.42M derived: sum of 2 quarters · filed 2022-02-11 | $19.99M derived: sum of 3 quarters · filed 2022-02-11 | $26.34M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $6.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $10.50M derived: sum of 2 quarters · filed 2022-02-11 | $16.85M derived: sum of 3 quarters · filed 2022-02-11 | $20.83M 10-K · filed 2022-02-11 |
| 2019-09-30 | $3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $9.92M derived: sum of 2 quarters · filed 2019-11-07 | $13.90M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $6.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $10.34M 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $3.99M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |